Hi Everyone, I just received this from another CML site that I am involved with and thought that I would pass it along. Hopefully it may help someone.
Dr. Shah at UCSF is enrolling patients for a stop dasatinib study. If you are interested, please contact study coordinator Anna Arauz at [email protected]. Some parameters for the study: "They must have been treated with dasatinib for at least two years, and in a dasatinib-induced complete molecular response for at least nine months. They cannot have had more than one prior TKI, and cannot have been treated with prior stem cell transplantation. Additionally, they cannot have ever had accelerated or blast phase CML." I'm just helping to spread the word! Feel free to forward as appropriate. Thanks! 18's, Marty -- -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope --- You received this message because you are subscribed to the Google Groups "CMLHope" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. For more options, visit https://groups.google.com/d/optout.
